Literature DB >> 27357578

VarI-SIG 2015: methods for personalized medicine - the role of variant interpretation in research and diagnostics.

Yana Bromberg1,2, Emidio Capriotti3, Hannah Carter4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27357578      PMCID: PMC4928159          DOI: 10.1186/s12864-016-2721-3

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


× No keyword cloud information.

Introduction

The growing availability of high-throughput sequencing continues to increase the number of identified genetic variants [1, 2]. For example, the size of the dbSNP database [3] has grown exponentially over the past years to ~150 million human single nucleotide polymorphisms and short genomic variants. Unfortunately, the characterization, annotation, and interpretation of these variants are still lagging. In particular, their implication in disease is one of the major challenges in personalized medicine [4-8]. The 5th edition of the Variant Interpretation Special Interest Group (VarI-SIG, formerly SNP-SIG) meeting [9-12] was held on July 11th, 2015 at the joint ISMB/ECCB meeting in Dublin, Ireland. The central VarI-SIG themes were “Annotation and prediction of structural/functional impacts of coding variants” and “Genetic variants as effectors of change: disease and evolution”. Our meeting is organized as a venue for the development of a research network of scientists, necessary for facilitating the exchange of ideas and establishing new collaborations. This year’s meeting attracted over 60 participants, with eight research talks and five presentations from the leading scientists in the field.

Manuscript submission and review

For this year’s VarI-SIG special issue we received eight manuscript submissions. All manuscripts were evaluated by at least two reviewers, selecting from a panel of three editors and 17 other experts in the field (see Acknowledgements). After 2 rounds of review seven manuscripts were accepted for publication. These address a description of a phenotype-dependent variant/gene prioritization method [13], annotation of variants specifically in protein kinases [14] and, generically, in regulatory regions [15], analysis of genetic variants associated with Alzheimer’s Disease [16], identification of the role of protein stability OMIM disease-related variants [17], and the study of mutation profiles in cancer genomes [18, 19]. [The complete program of VarI-SIG meeting 2015 with presentation and poster abstracts is available at http://varisig.biofold.org/2015/docs/vari-sig-2015-programme.pdf]

Further developments

We are working to organize the next VarI-SIG meeting (ISMB 2016; Orlando, Florida; July 9th, 2016). Further information about this coming meeting is available on our website (http://varisig.biofold.org). Last year, in collaboration with the ISMB organizers, we introduced VarI-COSI (Variant Interpretation Community of Special Interest). VarI-COSI is a community aimed at sharing relevant information, discussing ideas, and providing training and support networks in the field of genomic interpretation. The web portal for VarI-COSI is under development and is accessible via ISCB Connect (http://connect.iscb.org/home). We welcome input and participation from the variation interpretation community.
  12 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Building a genome analysis pipeline to predict disease risk and prevent disease.

Authors:  Y Bromberg
Journal:  J Mol Biol       Date:  2013-08-05       Impact factor: 5.469

Review 3.  Variation Interpretation Predictors: Principles, Types, Performance, and Choice.

Authors:  Abhishek Niroula; Mauno Vihinen
Journal:  Hum Mutat       Date:  2016-04-15       Impact factor: 4.878

4.  SNP-SIG 2013: from coding to non-coding--new approaches for genomic variant interpretation.

Authors:  Yana Bromberg; Emidio Capriotti
Journal:  BMC Genomics       Date:  2014-05-20       Impact factor: 3.969

5.  Bioinformatics challenges for personalized medicine.

Authors:  Guy Haskin Fernald; Emidio Capriotti; Roxana Daneshjou; Konrad J Karczewski; Russ B Altman
Journal:  Bioinformatics       Date:  2011-05-19       Impact factor: 6.937

6.  SNP-SIG Meeting 2011: identification and annotation of SNPs in the context of structure, function, and disease.

Authors:  Yana Bromberg; Emidio Capriotti
Journal:  BMC Genomics       Date:  2012-06-18       Impact factor: 3.969

7.  VarI-SIG 2014--From SNPs to variants: interpreting different types of genetic variants.

Authors:  Yana Bromberg; Emidio Capriotti
Journal:  BMC Genomics       Date:  2015-06-18       Impact factor: 3.969

8.  Guidelines for investigating causality of sequence variants in human disease.

Authors:  D G MacArthur; T A Manolio; D P Dimmock; H L Rehm; J Shendure; G R Abecasis; D R Adams; R B Altman; S E Antonarakis; E A Ashley; J C Barrett; L G Biesecker; D F Conrad; G M Cooper; N J Cox; M J Daly; M B Gerstein; D B Goldstein; J N Hirschhorn; S M Leal; L A Pennacchio; J A Stamatoyannopoulos; S R Sunyaev; D Valle; B F Voight; W Winckler; C Gunter
Journal:  Nature       Date:  2014-04-24       Impact factor: 49.962

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Thoughts from SNP-SIG 2012: future challenges in the annotation of genetic variations.

Authors:  Yana Bromberg; Emidio Capriotti
Journal:  BMC Genomics       Date:  2013-05-28       Impact factor: 3.969

View more
  1 in total

1.  Blind prediction of deleterious amino acid variations with SNPs&GO.

Authors:  Emidio Capriotti; Pier Luigi Martelli; Piero Fariselli; Rita Casadio
Journal:  Hum Mutat       Date:  2017-05-02       Impact factor: 4.878

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.